The principal objectives of the proposed work are to use linkage studies, in silico gene identification,cartilage gene expression and mutation analysis of functional and positional candidates to identify thedisease genes in osteochondrodysplasias of unknown etiology. The linkage studies will use familiescollected by outreach efforts and referral to the International Skeletal Dysplasia Registry (Core A). Thedisorders to be studied have been selected based on criteria that include their frequency, the likelihood thatidentification of the disease gene will reveal an essential component of an important biological pathway, theability to use the molecular information to improve definition of the diagnostic features and inheritancepattern(s) within a phenotypic group and the relevance to studies under the other components of theProgram Project. Through these studies, we will define new molecular mechanisms for the skeletaldysplasias and understand the normal functions of skeletal dysplasia disease genes.
The Specific Aims areto identify the loci and disease genes in three phenotypic groups: 1. Short rib polydactyly and asphxiatinq thoracic dysplasia. These two perinatal lethal disorders areamong the most frequent lethal skeletal dysplasias. They have been grouped together in the classification ofskeletal dysplasias based on shared phenotypic features and have been hypothesized to be part of aspectrum of disease that includes chondroectodermal dysplasia. We will test the hypothesis that they areeither allelic or that the disease genes are components of a pathway. 2. Recessive osteogenesis imperfecta (Ol). Knockout mice with deficiency of Crtap have a defect inprolyl hydroxylation that leads to an undermineralized skeleton resembling osteogenesis imperfecta. Thegoal of this aim is to work in collaboration with the other Projects and Cores to identify human recessive Olphenotypes with mutations in CRTAP. In cases where CRTAP is excluded, additional candidate loci will beconsidered, including a newly identified locus on chromosome 17q21-22. These interactive studies willfacilitate the definition of both the molecular basis and the clinical and histological features that characterizenovel mechanismsfor recessively inherited osteogenesis imperfecta. 3. Brachyolmia. Brachyolmia is a form of short trunk short stature with a characteristic platyspondyly andirregular margins of the vertebral bodies. The phenotype is clinically and genetically heterogeneous withdominant and recessive forms described. The goal of this aim is to use linkage studies to define the firstbrachyolmia locus and to determine the diagnostic features and natural history of the entity. Identification ofa disease gene for dominant brachyolmia will promote clarification of the diagnostic features of each formand will help define the biological basis of the phenotype

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
2P01HD022657-21A1
Application #
7245970
Study Section
Pediatrics Subcommittee (CHHD)
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
21
Fiscal Year
2007
Total Cost
$399,175
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Joeng, Kyu Sang; Lee, Yi-Chien; Lim, Joohyun et al. (2017) Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis. J Clin Invest 127:2678-2688
Madan, Simran; Liu, Wei; Lu, James T et al. (2017) A non-mosaic PORCN mutation in a male with severe congenital anomalies overlapping focal dermal hypoplasia. Mol Genet Metab Rep 12:57-61
Rajagopal, Abbhirami; Homan, Erica P; Joeng, Kyu Sang et al. (2016) Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice. Mol Genet Metab 117:378-82
Xue, Yuan; Schoser, Benedikt; Rao, Aliz R et al. (2016) Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death. Circ Cardiovasc Genet 9:130-5
Lietman, Caressa D; Marom, Ronit; Munivez, Elda et al. (2015) A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res 30:489-98
Hudson, David M; Joeng, Kyu Sang; Werther, Rachel et al. (2015) Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations. J Biol Chem 290:8613-22
Chen, Shan; Grover, Monica; Sibai, Tarek et al. (2015) Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. Mol Genet Metab 115:53-60
Weinstein, Michael M; Tompson, Stuart W; Chen, Yuqing et al. (2014) Mice expressing mutant Trpv4 recapitulate the human TRPV4 disorders. J Bone Miner Res 29:1815-1822
Joeng, Kyu Sang; Lee, Yi-Chien; Jiang, Ming-Ming et al. (2014) The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations. Hum Mol Genet 23:4035-42
Campeau, Philippe M; Kasperaviciute, Dalia; Lu, James T et al. (2014) The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol 13:44-58

Showing the most recent 10 out of 365 publications